Domov › Srdcové zlyhanie › Missouri › St. Louis
Klinické štúdie Srdcové zlyhanie v meste St. Louis, MO
26 štúdií pre Srdcové zlyhanie hľadá účastníkov v zariadeniach v meste St. Louis a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Prebieha náborFáza 2
- Washington University School of Medicine, St Louis
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Prebieha náborFáza 3
- St. Louis Heart and Vascular, P.C., St Louis
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Prebieha náborFáza 3
- St. Louis Heart and Vascular, P.C., St Louis
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Prebieha náborFáza 3
- Research Site, Bridgeton · 15 míľ odtiaľ
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Prebieha náborFáza 3
- Washington University Center for Advanced Medicine, St Louis
A Study of LY3971297 in Participants With Heart Failure
Prebieha náborFáza 1
- Washington University, St Louis
Alleviant ALLAY-HFrEF Study
Prebieha nábor
- Washington University - St Louis, St Louis
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Prebieha náborFáza 3
- Research Site, St Louis
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Prebieha nábor
- WashU Medicine, St Louis
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
Prebieha náborFáza 2
- Local Institution - 109, St Louis
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Prebieha náborFáza 2/3
- Washington University-Pediatric Cardiology/ St. Louis Children's Hospital ( Site 0006), St Louis
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Prebieha náborFáza 2
- Washington University Center for Advanced Medicine, St Louis
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Prebieha náborObservačná štúdia
- St Louis, St Louis
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Prebieha náborObservačná štúdia
- Washington University, St Louis
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Prebieha náborFáza 3
- Tenax Investigational Site, St Louis
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Prebieha náborFáza 3
- Washington University, St Louis
- Amicis Centers of Clinical Research, St Louis
Alleviant ALLAY-HF Study
Prebieha nábor
- Washington University - St Louis, St Louis
Assessment of CCM in HF With Higher Ejection Fraction
Prebieha nábor
- St. Louis Heart and Vascular, Bridgeton · 15 míľ odtiaľ
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
Prebieha náborFáza 3
- Washington Univ School Of Medicine, St Louis
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Prebieha náborFáza 3
- Washington University - St. Louis Children's Hospital - Cardiology, St Louis
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Prebieha náborFáza 3
- Washington University - St. Louis Children's Hospital - Cardiology, St Louis
The Inorganic Nitrate and eXercise Performance in Heart Failure (iNIX-HF)
Prebieha náborFáza 2
- Washington University School of Medicine, St Louis
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Prebieha nábor
- St. Louis Heart and Vascular, St Louis
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Prebieha náborFáza 3
- Washington University, St Louis
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Prebieha nábor
- Washington University - Barnes Jewish Health Hospital, St Louis
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Prebieha náborFáza 1/2
- Washington University in Saint Louis, St Louis
Štúdie Srdcové zlyhanie v iných mestách
- New York City, NY51 štúdií
- Boston, MA44 štúdií
- Dallas, TX42 štúdií
- Houston, TX36 štúdií
- Cleveland, OH33 štúdií
- Chicago, IL31 štúdií
- Philadelphia, PA31 štúdií
- San Francisco, CA29 štúdií
- Durham, NC26 štúdií
- Atlanta, GA25 štúdií
- Kansas City, MO25 štúdií
- Cincinnati, OH24 štúdií
Iné štúdie v St. Louis
- Nemalobunkový karcinóm pľúc73 štúdií
- Rakovina prsníka64 štúdií
- Metastatická rakovina54 štúdií
- Kolorektálny karcinóm50 štúdií
- Rakovina (všetky typy)46 štúdií
- Rakovina prostaty46 štúdií
- Rakovina pľúc39 štúdií
- Rakovina vaječníkov38 štúdií
- Rakovina pankreasu33 štúdií
- Rakovina endometria29 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku28 štúdií
- Obézita25 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.